Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest
Key facts
- Who runs it
- Azienda Usl di Bologna
- Where
- Italy2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 52,720 people, planned
- Started
- 10 Jun 2026
- Expected to end
- 30 Jul 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Opioids (ATC N02A)
- Antiepileptics (ATC N03A)
- Antipsychotics (ATC N05A)
- Antidepressants (ATC N06A)
- Record updated
- 20 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18 years or older
- Resident in the Local Health Authority of Bologna catchment area
- Trauma cohort: urgent ordinary-regime hospital admission with a discharge diagnosis in ICD-9-CM codes 800-999 and at least one injury with Abbreviated Injury Scale (AIS) severity of 1 or higher, between 2014 and 2024
- Cardiac arrest cohort: emergency department admission for out-of-hospital cardiac arrest with subsequent hospital discharge and ICD-9-CM code 427.5
- Residence and vital status confirmed on linkage to population records
Who cannot take part
- Death in hospital or within one day after discharge
- Non-resident or vital status not confirmable
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This retrospective population-based cohort study uses linked administrative healthcare data from the Local Health Authority of Bologna (Italy) to describe the use of four classes of psychoactive drugs (opioids, antiepileptics, antipsychotics, and antidepressants) after hospital discharge in two populations, adults admitted urgently for trauma and adults surviving out-of-hospital cardiac arrest, and to evaluate whether post-discharge exposure is associated with low-acuity or incomplete emergency department visits and urgent hospital readmissions within one year. Exposure is derived from outpatient dispensing records and classified as naive (started after discharge), long-term (before and after), or interrupted, and as current or not current over follow-up. Associations are estimated with marginal count regression models adjusted for demographics, illness or injury severity, and comorbidity, separately for each cohort.
The 2 groups in the trial
- Trauma cohort
Adults resident in the Local Health Authority of Bologna discharged alive after an urgent ordinary-regime hospital admission for trauma (ICD-9-CM 800-999) between 2014 and 2024. Post-discharge exposure to opioids, antiepileptics, antipsychotics, and antidepressants is assessed from outpatient dispensing records.
Treatment: Opioids (ATC N02A), Antiepileptics (ATC N03A), Antipsychotics (ATC N05A), and Antidepressants (ATC N06A)
- Out-of-hospital cardiac arrest cohort
Adults resident in the Local Health Authority of Bologna admitted to the emergency department after out-of-hospital cardiac arrest and discharged alive from hospital (ICD-9-CM 427.5). Post-discharge exposure to opioids, antiepileptics, antipsychotics, and antidepressants is assessed from outpatient dispensing records.
Treatment: Opioids (ATC N02A), Antiepileptics (ATC N03A), Antipsychotics (ATC N05A), and Antidepressants (ATC N06A)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Long-Term Impact of Psychoactive Medications After Trauma and Cardiac Arrest: A Retrospective Cohort Study on Prevalence and Impact on Emergency Department and Hospital Readmissions
- Record updated
- 20 October 2026